Related Experiment Videos
Duodenal switch--the initial experience in New Zealand
Martyn L Humphreys1, Steven J Robinson, Caryne McKeand
1Department of Surgery, North Shore Hospital, Shakespeare Road, Takapuna, Auckland 0622, New Zealand. mlhumphreys75@gmail.com.
The New Zealand Medical Journal
|May 9, 2014
Summary
The duodenal switch (DS) is an effective bariatric surgery for morbid obesity, showing significant excess weight loss and high comorbidity resolution rates. Careful follow-up is crucial for safety and optimal outcomes.
Area of Science:
- Bariatric surgery
- Surgical procedures
- Metabolic and bariatric surgery
Background:
- The duodenal switch (DS) is recognized as an effective, durable, and safe bariatric procedure.
- Initial patient data collection occurred between May 2008 and November 2012.
Purpose of the Study:
- To present the initial experience with the duodenal switch procedure in 60 patients.
- To evaluate the efficacy and safety of DS in managing morbid obesity and its comorbidities.
Main Methods:
- Retrospective case series utilizing a prospective database.
- Follow-up data was collected for 94.8% of patients over 4 years.
Main Results:
- Mean initial BMI was 52.8 kg/m². Excess weight loss reached 69.5% at 1 year and 73.1% at 2 years.
- High comorbidity resolution rates: 95% for diabetes, 100% for obstructive sleep apnea, 72% for hypertension, 92% for dyslipidemia.
- Mean hospital stay was 5.08 days; one death occurred due to liver failure secondary to poor compliance.
Conclusions:
- Short-term analysis indicates DS is highly efficient for morbid obesity and comorbidity cure.
- DS appears safe when appropriate follow-up regimens are adhered to, offering a favorable risk/benefit profile.